{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:28:02Z","timestamp":1786436882893,"version":"build-2736575974"},"reference-count":22,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","award":["223187\/Z\/21\/Z"],"award-info":[{"award-number":["223187\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>The coexistence of diabetes and hyperinsulinemic hypoglycemia (HI) within a family is rare. Activating MAFA variants have been described in 3 families with this dual phenotype and are associated with sex-dependent clinical patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied a family where members were affected by HI (n = 5), diabetes (n = 5), or both conditions (n = 1). Clinical, biochemical, and imaging data were collected. Genetic testing for variants in known monogenic diabetes and HI genes was performed in the proband, followed by cascade testing in available relatives. Pancreatic tissue was examined by immunohistochemistry and immunofluorescence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A heterozygous, p.(Ser64Phe) MAFA variant was identified in the male proband, who had presented with diabetes at 28 years and developed HI due to insulinomatosis 6 years later. The variant was confirmed in 5 relatives, 4 with HI and 1 with diabetes (including obligate heterozygotes). Among the 5 presenting with HI, 3 were female, whereas 4 of 6 presenting with diabetes were male, consistent with reported sex-dependent patterns.<\/jats:p>\n                    <jats:p>Increased nuclear expression of the transcription factor MafA (MAFA) was detected by immunofluorescence in insulin-positive tumor regions compared to the adjacent islets, supporting a pathogenic role for the variant in beta-cell regulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We describe the fourth family with a pathogenic MAFA variant and the second individual with the dual phenotype of diabetes and HI. Our findings highlight challenges in clinical management of this condition and underscore the need to consider MAFA in cases of adult-onset HI or those with an atypical course of diabetes especially when there is family history.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag145","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:14:10Z","timestamp":1786101250000},"source":"Crossref","is-referenced-by-count":0,"title":["Dual phenotype in a patient with adult-onset hyperinsulinism and diabetes caused by an activating\n                    <i>MAFA<\/i>\n                    variant"],"prefix":"10.1210","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7885-8195","authenticated-orcid":false,"given":"Evgenia","family":"Globa","sequence":"first","affiliation":[{"name":"Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine , Kyiv 01021 ,","place":["Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R","family":"Hopkinson","sequence":"additional","affiliation":[{"name":"Clinical and Biomedical Science, University of Exeter , Exeter EX2 5DW ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S","family":"Flaxman","sequence":"additional","affiliation":[{"name":"Clinical and Biomedical Science, University of Exeter , Exeter EX2 5DW ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaelis","family":"Vasiliadis","sequence":"additional","affiliation":[{"name":"Clinical and Biomedical Science, University of Exeter , Exeter EX2 5DW ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1160-6062","authenticated-orcid":false,"given":"Sarah J","family":"Richardson","sequence":"additional","affiliation":[{"name":"Clinical and Biomedical Science, University of Exeter , Exeter EX2 5DW ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"H\u00f8jlund","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center, Odense University Hospital , DK-5000 Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6nke","family":"Detlefsen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Odense University Hospital , DK-5000 Odense ,","place":["Denmark"]},{"name":"Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark , DK-5230 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8670-6340","authenticated-orcid":false,"given":"Sarah E","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Clinical and Biomedical Science, University of Exeter , Exeter EX2 5DW ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"9354","key":"2026081103320481000_bvag145-B1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(03)12325-2","article-title":"A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1","volume":"361","author":"Huopio","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"2026081103320481000_bvag145-B2","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1371\/journal.pmed.0040118","article-title":"Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene","volume":"4","author":"Pearson","year":"2007","journal-title":"PLoS Med"},{"issue":"10","key":"2026081103320481000_bvag145-B3","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00125-011-2207-4","article-title":"Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8\/KCNJ11 mutations","volume":"54","author":"Kapoor","year":"2011","journal-title":"Diabetologia"},{"issue":"6","key":"2026081103320481000_bvag145-B4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/db07-1657","article-title":"Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations","volume":"57","author":"Kapoor","year":"2008","journal-title":"Diabetes"},{"issue":"5","key":"2026081103320481000_bvag145-B5","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1073\/pnas.1712262115","article-title":"MAFA missense mutation causes familial insulinomatosis and diabetes mellitus","volume":"115","author":"Iacovazzo","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8035","key":"2026081103320481000_bvag145-B6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0140-6736(77)90609-2","article-title":"Familial islet-cell adenomatosis","volume":"2","author":"Tragl","year":"1977","journal-title":"Lancet"},{"issue":"7","key":"2026081103320481000_bvag145-B7","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/cancers14071798","article-title":"Second MAFA variant causing a phosphorylation defect in the transactivation domain and familial insulinomatosis","volume":"14","author":"Fottner","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2026081103320481000_bvag145-B8","doi-asserted-by":"crossref","first-page":"109813","DOI":"10.1016\/j.celrep.2021.109813","article-title":"Sex-biased islet beta cell dysfunction is caused by the MODY MAFA S64F variant by inducing premature aging and senescence in males","volume":"37","author":"Walker","year":"2021","journal-title":"Cell Rep"},{"issue":"9","key":"2026081103320481000_bvag145-B9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc2460","article-title":"A new MAFia in cancer","volume":"8","author":"Eychene","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2026081103320481000_bvag145-B10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.onc.1201898","article-title":"Mafa, a novel member of the maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells","volume":"17","author":"Benkhelifa","year":"1998","journal-title":"Oncogene"},{"issue":"39","key":"2026081103320481000_bvag145-B11","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.1038\/sj.onc.1206526","article-title":"Mafa has strong cell transforming ability but is a weak transactivator","volume":"22","author":"Nishizawa","year":"2003","journal-title":"Oncogene"},{"issue":"12","key":"2026081103320481000_bvag145-B12","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1128\/MCB.25.12.4969-4976.2005","article-title":"Mafa is a key regulator of glucose-stimulated insulin secretion","volume":"25","author":"Zhang","year":"2005","journal-title":"Mol Cell BiolJun"},{"issue":"6","key":"2026081103320481000_bvag145-B13","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/db13-1001","article-title":"The MafA transcription factor becomes essential to islet beta-cells soon after birth","volume":"63","author":"Hang","year":"2014","journal-title":"Diabetes"},{"key":"2026081103320481000_bvag145-B14","doi-asserted-by":"publisher","author":"Globa","DOI":"10.24378\/exe.32360751.v1"},{"issue":"3","key":"2026081103320481000_bvag145-B15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026081103320481000_bvag145-B16","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1007\/s00125-013-2962-5","article-title":"Improved genetic testing for monogenic diabetes using targeted next-generation sequencing","volume":"56","author":"Ellard","year":"2013","journal-title":"Diabetologia"},{"issue":"3","key":"2026081103320481000_bvag145-B17","doi-asserted-by":"crossref","first-page":"e1009940","DOI":"10.1371\/journal.pcbi.1009940","article-title":"SavvyCNV: genome-wide CNV calling from off-target reads","volume":"18","author":"Laver","year":"2022","journal-title":"PLoS Comput BiolMar"},{"issue":"6509","key":"2026081103320481000_bvag145-B18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"The GTEx Consortium","year":"2020","journal-title":"Science"},{"issue":"3","key":"2026081103320481000_bvag145-B19","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/dme.12369","article-title":"HNF4A mutation: switch from hyperinsulinaemic hypoglycaemia to maturity-onset diabetes of the young, and incretin response","volume":"31","author":"Arya","year":"2014","journal-title":"Diabet Med"},{"issue":"5","key":"2026081103320481000_bvag145-B20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1530\/EJE-09-0861","article-title":"Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations","volume":"162","author":"Flanagan","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026081103320481000_bvag145-B21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1086\/520960","article-title":"Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells","volume":"81","author":"Otonkoski","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2026081103320481000_bvag145-B22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12022-022-09705-5","article-title":"Overview of the 2022 WHO classification of familial endocrine tumor syndromes","volume":"33","author":"Nose","year":"2022","journal-title":"Endocr Pathol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/9\/bvag145\/70607340\/bvag145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/9\/bvag145\/70607340\/bvag145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:32:10Z","timestamp":1786433530000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag145\/8758714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag145","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,1]]},"article-number":"bvag145"}}